Developments in the discovery and design of intranasal antidepressants-Reference-Cited by-同舟云学术

Developments in the discovery and design of intranasal antidepressants

Published:2020-06-21 Issue:10 Volume:15 Page:1145-1164
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Panek Małgorzata¹,Kawalec Paweł²³,Pilc Andrzej²³,Lasoń Władysław²

Affiliation:

1. Faculty of Food Technology, University of Agriculture, Krakow, Poland

2. Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland

3. Drug Management Department, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University, Kraków, Poland

Funder

Maj Institute of Pharmacology of the Polish Academy of Sciences

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2020.1776697

Reference102 articles.

1. Antidepressants [Internet]. National Institute of Mental Health; 2018 Aug [cited 2019 Oct 10]. Available from: https://www.nhs.uk/conditions/antidepressants/

2. A brief history of the development of antidepressant drugs: From monoamines to glutamate.

3. Antidepressant Utilization and Suicide in Europe: An Ecological Multi-National Study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary inhalation for disease treatment: Basic research and clinical translations;Materials Today Bio;2024-04

2. The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review;Pharmaceutics;2023-12-13

3. Exploring the potential to enhance drug distribution in the brain subregion via intranasal delivery of nanoemulsion in combination with borneol as a guider;Asian Journal of Pharmaceutical Sciences;2023-11

4. Intranasal (R, S)-ketamine delivery induces sustained antidepressant effects associated with changes in cortical balance of excitatory/inhibitory synaptic activity;Neuropharmacology;2023-03

5. Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients;Pharmaceutics;2022-09-28